Healthcare -
Biotechnology - NASDAQ - US
$ 0.84
-0.838 %
$ 65.7 M
Market Cap
5.25
P/E
CTMX - OPERATING INCOME
Operating Income CTMX - CytomX Therapeutics, Inc.
-6.48 M
LAST VALUE
72.18%
2 YEAR CAGR
39.17%
5 YEAR CAGR
8.02%
10 YEAR CAGR